YuanBao Medical Completes Tens of Millions RMB Angel Round Led by Shanghai Sci-Tech IP Fund, Advances Non-Invasive Closed-Loop Brain-Computer Interface and Neural Rehabilitation

VCBeat learned that recently, Shanghai Yuanbao Medical Device Co., Ltd. announced the completionTens of Millions of Yuan in Angel Round Financing. This round of financing was led byIntellectual Property Fund under Shanghai Sci-Tech Investment GroupExclusive strategic investment. The funds raised will be mainly used forIntelligent Precision Neural Circuit Multi-Target Regulation Robotic SystemAndMRI Target Calculation AI SystemThe R&D iteration, clinical registration application, benchmark market expansion, and continuous innovation in cutting-edge technologies of the two core products are propelling the company to accelerate its leading position in the fields of neurorehabilitation and brain-computer interfaces.

Since its establishment in 2022, Shanghai Yuanbao Medical Device Co., Ltd. has always been deeply engaged inBrain Science, Intelligent Neuromodulation and NeurorehabilitationInterdisciplinary Field, Focused on Functional Disorders of Brain DiseasesIndividualized, Precise, and Intelligent Diagnosis, Treatment, and Rehabilitation, committed to building fromFrom basic research, technology development, clinical translation to industrial implementationThe full-chain innovation system. The company's core team brings together top experts in the fields of brain science, neurorehabilitation, medical imaging, artificial intelligence, medical robotics, and clinical medicine, creating an innovative ecosystem that integrates multidisciplinary collaboration and deep integration of industry, academia, and research.

Relying on &Engineering Center for Intelligent Rehabilitation of Traditional Chinese Medicine, Ministry of Education, Shanghai University of Traditional Chinese MedicineCo-builtPrecision Neural Circuit Multi-Target Regulation Joint Laboratory, in collaboration with the Intelligent Robotics Research Center of Zhejiang University, developed a core force control adhesion algorithm. The company has successfully completed the critical leap from core technology breakthrough to product implementation, forming an independently controlled and internationally competitive technical barrier.

The company breaks through the technical limitations of traditional single-target and local brain region stimulation, based onFull Information Decoding of Brain Function-Structure, throughMultimodal Brain Imaging (fMRI, DTI) and High-Density EEG Fusion Analysis, achieving precise identification, dynamic calibration, and quantitative assessment of damaged brain networks.

Innovatively proposed "symptom-circuit mapping"-orientedTranscranial Magnetic Stimulation Therapy Theory，Taking neural circuits as the core unit of disease intervention, breaking down the barriers between basic neuroscience, clinical rehabilitation needs, and intelligent equipment development, for major brain diseases such as stroke and cognitive impairment.Providing original theoretical support for non-invasive, precise, and closed-loop regulation, truly realizing the conceptual innovation from "local brain area intervention" to "whole-brain network regulation."

Company ConstructionEEG Signals + Functional Structural ImagingA multimodal fusion-based neural circuit decoding system for comprehensive, precise, and individualized analysis of brain function-structure information:

(1) EstablishmentVoxel-Level Individualized Neural Circuit Mapping Technology, integrating fMRI functional connectivity, DTI white matter fiber bundle anatomical connectivity, and high-density EEG spatiotemporal dynamic characteristics to achieve neural circuitPrecision Calibration, Functional Analysis, Target Localization, providing objective, quantifiable, and repeatable target basis for individualized neuromodulation. The relevant core technologies have been granted multiple national invention patents.

(2) The first to introduce synapticPlasticity Learning Rules (Hebbian Mechanism)Integrating non-invasive neuromodulation, innovatively developing paired associative stimulation technology, breaking through the industry bottleneck where traditional transcranial magnetic stimulation struggles to modulate deep brain nuclei and long-range neural circuits, constructingCortical-Subcortical-Neural CircuitFull-dimensional "Point-Line-Plane" Intelligent Neural Modulation System, AchievingSpatiotemporal precision targeting, deep non-invasive, circuit-level precise intervention, the world's first original patent technology for neural circuit modulation that can be directly applied in clinical settings.

The company willHebbian Pattern Paired Stimulation, Individualized Neural Circuit Targets, Intelligent Spatiotemporal Targeted RegulationDeep integration to form a standardized, replicable, and promotable clinical treatment system. For major diseases such as amnestic mild cognitive impairment, upper limb motor dysfunction after stroke, and balance dysfunction, independently developed customized intelligent modulation paradigms such as ccPAS and Circuits-Based PAS, and systematically verified the significant efficacy of the technology in improving cognitive, motor, and balance dysfunctions through multi-center, double-blind, randomized controlled clinical studies, truly achievingFrom Mechanism Innovation, Technology Development to Clinical BenefitsThe complete transformation chain.

Relying onFull Information Decoding of EEG-Imaging Neural CircuitsCode and "Point-Line-Surface" Intelligent Neural Modulation Core Competencies, the company has taken the lead in enteringThe Era of Neuromodulation 2.0—— From Single Cortex Stimulation toCortical-Subcortical Long-Range Circuit Modulation; From fixed-target stimulation, moving towardsIndividualized, Dynamic, Spatiotemporal Precision Targeting; From passive intervention, moving towardsA Non-Invasive Brain-Computer Interface Closed-Loop System of Perception-Decoding-Decision-Regulation-Feedback。

The company's two core products jointly build a complete ecosystem for intelligent neurorehabilitation:

· Intelligent Precision Neural Circuit Multi-Target Regulation Robotic System

Through multi-modal visual positioning, AI analysis of medical images, intelligent linkage of robotic arms, and real-time navigation, the neuromodulation coil is achieved.Initial precise positioning, dynamic precision during the process, and long-term repetitive precision, ensuring the stability and reliability of loop-level multi-target synergistic regulation, and providing core equipment support for large-scale, standardized, and intelligent neurorehabilitation in clinical settings.

· AI System for Magnetic Resonance Imaging Target Calculation

Based on high-precision post-processing of full-modal brain imaging, voxel-level neural circuit Mapping algorithms, and artificial intelligence models,MRI Target Calculation AI Integrated Machine, which can quickly complete individualized neural circuit analysis, automatic target recognition, and precise coordinate calculation, providingClosed-loop brain-computer interface, intelligent neuromodulation, TCM-brain-computer collaborationProvide underlying algorithms and data support.

Zhang Chao, head of Farcare Medical, said:Thank you to Shanghai Sci-Tech Innovation Group and the Intellectual Property Fund for their high recognition and strategic support of Yuanbao Medical's technology roadmap, team, and clinical value. This round of financing will provide strong momentum for the company's technology transfer, product implementation, and market expansion. In the future, the company will continue to adhere toOriginal Innovation, Clinical Orientation, Industrial EmpowermentThe development philosophy, efficient and standardized operation of funds, continuous strengthening of core technology barriers, and acceleration of clinical registration and commercialization.

At the same time, the company will actively layoutNon-invasive brain-computer interface, TCM brain-computer fusion, closed-loop intelligent neuromodulationand other frontier directions, committed to becoming a connectionFrontier Brain Science Research and Clinical Transformation ApplicationsAn important bridge, creating a domestically leading and internationally first-class brain disease rehabilitation and brain-computer interface innovation platform, contributing to China's high-end medical equipment autonomy, Chinese production substitution, and high-quality development.

Shanghai Sci-Tech Innovation Group's Intellectual Property Fund stated:The Intellectual Property Fund focuses on the key layout of Shanghai's "3+6" new industrial system in the long term, firmly implementing the strategy of science and technology innovation, and adhering to investing early, small, in hard technology, and core intellectual property.Neuromodulation, Brain-Computer Interface, and High-End Rehabilitation Device TracksWith broad clinical demand and significant space for domestic production, it is a core direction of strategic value in the life and health field.

FarCare Medical inNeural Circuit Decoding, Non-invasive Deep Modulation, Intelligent Rehabilitation Robot, Brain-Computer Interface...and other fields possess original theories, core patents, clinical validation, and productization capabilities, with prominent technical barriers, clear clinical value, and a well-defined commercialization path. In the future, the fund will fully leverage its industrial resources and capital advantages to continuously empower Yuanbao Medical, assisting the company in accelerating technological iteration, clinical transformation, and market expansion, growing into a globally leading benchmark enterprise in the field of neuromodulation and brain-computer interface.

The Intellectual Property Fund, established in September 2016, is the first mixed-ownership reform demonstration fund under Shanghai Technology Venture Capital Investment (Group) Co., Ltd. It is also a key component of Shanghai Sci-Tech Innovation Group's "1+3" fund system, shouldering important missions such as the group's market-oriented reform, the construction of a mixed-ownership venture capital platform, and the implementation of the sci-tech innovation strategy.

Positioned as the "light cavalry" of scientific and technological innovation and the "small window" for external cooperation, the fund relies on the advantages of market-oriented mechanisms, focusing on original innovation and industrial transformation. It centers around the key links of Shanghai Science and Technology Innovation Group's "from 0 to 1 original innovation" and "from 1 to 10 industrial innovation," coordinating multiple resources to promote the transformation of cutting-edge scientific and technological achievements, the growth of hardcore technology enterprises, and the construction of a high-end industrial ecosystem. It aims to build a science and technology investment brand with influence across China.